Multiplex Biomarker Imaging Market: By Product Type, By Imaging Technique, Toponome Imaging System, Fluorescent In The Situ Hybridization, Immunofluorescence Assay, Immunohistochemistry Assay ), By Application, By End-User, and Region Forecast 2020-2031
Multiplex Biomarker Imaging Market size was valued at US$ 526.4 million in 2024 and is expected to reach US$ 1,171.0 million by 2031, growing at a significant CAGR of 12.1% from 2025-2031. An increase in the adoption of the multiplex biomarker in immunology and oncology research, growing R&D investments by pharmaceutical and biotechnology companies, an increase in demand for personalized medicine, and innovation of newer technologies in biomarker imaging are anticipated to fuel the market size over the forecast period. Moreover, an increase in preference for companion diagnostics and the advantages of multiplex biomarker imaging over conventional methods are anticipated to boost the market report over the forecast years.
However, the high cost of the instruments, ethical issues of biomarker imaging techniques, and stringent regulatory policies are anticipated to impede the growth of the market. Multiplex biomarker imaging is a technique carried to characterize and analyze the disease present in the body. Biomarkers are used in clinical studies to determine the disease's progress. Multiplex biomarkers have a major role in the medical industry and these are used in alone or combination to determine the characteristics and evaluate as an indicator of biological process. Multiplex biomarkers also help in the study of biological system by providing analysis to check the expression of various biomarkers. In August 2017, Quanterix launched high-sensitivity instrument Quanterix SR-Plex and assays for multiplex biomarker detection.
Study Period
2025-2031Base Year
2024CAGR
12.1%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Multiplex biomarker imaging market expected to exhibit significant growth due to successful determination and validation of clinical data for various diseases related to cancer cells and immune cells. Majority of the market players are actively involved in the development of newer products and techniques to determine the disease progress. For instance, in December 2015, PerkinElmer, Inc. launched Vectra 3 system used to determine the deeper level analysis of disease mechanisms related to newer cancer immunotherapy approaches. Moreover, in September 2017, Aushon BioSystems and ABL, Inc. announced the adoption of Cira platform for ultrasensitive and multiplex biomarker analysis.
North America market is driven by increase in the R&D activities for drug discovery, innovation of newer assays, and launching of newer products for multiplex biomarker imaging in the market. Europe market has a significant share, which is attributed to adoption of newer technologies, presence of huge number of biotechnology research institutions, and increase in the prevalence of cancer and other immune disorders in the region. Asia Pacific market has a lucrative growth opportunity owing to ongoing research for cancer and tumor, rise in prevalence of cancer, and growing R&D activities by pharmaceutical companies for drug discovery and drug safety are expected to bolster the market. Latin America market is poised to grow at a significant rate due to increase in the biotech R&D activities by collaboration between the market players and increase in the demand for drug safety are expected to propel the market. Middle East and Africa market is projected to grow due to increase in the prevalence of immune disorders in Africa region and increase in the preference for personalized medicine are expected to upsurge market revenue growth.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 526.4 million |
|
Market Size in 2031 |
US$ 1,171.0 million |
|
Market CAGR |
12.1% |
|
By Product Type |
|
|
By Imaging Technique |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global multiplex biomarker imaging market size was valued at US$ 526.4 million in 2024 and is expected to reach US$ 1,171.0 million by 2031, growing at a significant CAGR of 12.1% from 2025-2031.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The multiplex biomarker imaging market key players are Bio-rad Laboratories Inc. (U.S.) Abcam plc. (U.K.) Perkin Elmer, Inc. (U.S.) Thermo Fisher Scientific, Inc. (U.S.) Merck KGaA (Germany) Aushon BioSystems Ltd. (U.S.)
| 1. Executive Summary |
| 2. Global Multiplex Biomarker Imaging Market Introduction |
| 2.1.Global Multiplex Biomarker Imaging Market - Taxonomy |
| 2.2.Global Multiplex Biomarker Imaging Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Imaging Technique |
| 2.2.3.Application |
| 2.2.4.End User |
| 2.2.5.Region |
| 3. Global Multiplex Biomarker Imaging Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Multiplex Biomarker Imaging Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Multiplex Biomarker Imaging Market By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Instrument |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Reagents and Kits |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Software |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Multiplex Biomarker Imaging Market By Imaging Technique, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Tissue Microarray (TMA) |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Toponome Imaging System (TIS) |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Fluorescent In The Situ Hybridization (FISH) |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Immunofluorescence Assay (IF) |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Immunohistochemistry Assay (IHC) |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Multiplex Biomarker Imaging Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Oncology |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Immunology |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Drug Safety |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Drug Discovery |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Multiplex Biomarker Imaging Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Biotechnology and Pharmaceutical Companies |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Academic Research Institutes |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Contract Research Organizations |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Multiplex Biomarker Imaging Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Multiplex Biomarker Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Instrument |
| 10.1.2.Reagents and Kits |
| 10.1.3.Software |
| 10.2. Imaging Technique Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Tissue Microarray (TMA) |
| 10.2.2.Toponome Imaging System (TIS) |
| 10.2.3.Fluorescent In The Situ Hybridization (FISH) |
| 10.2.4.Immunofluorescence Assay (IF) |
| 10.2.5.Immunohistochemistry Assay (IHC) |
| 10.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Oncology |
| 10.3.2.Immunology |
| 10.3.3.Drug Safety |
| 10.3.4.Drug Discovery |
| 10.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Biotechnology and Pharmaceutical Companies |
| 10.4.2.Academic Research Institutes |
| 10.4.3.Contract Research Organizations |
| 10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Multiplex Biomarker Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Instrument |
| 11.1.2.Reagents and Kits |
| 11.1.3.Software |
| 11.2. Imaging Technique Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Tissue Microarray (TMA) |
| 11.2.2.Toponome Imaging System (TIS) |
| 11.2.3.Fluorescent In The Situ Hybridization (FISH) |
| 11.2.4.Immunofluorescence Assay (IF) |
| 11.2.5.Immunohistochemistry Assay (IHC) |
| 11.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Oncology |
| 11.3.2.Immunology |
| 11.3.3.Drug Safety |
| 11.3.4.Drug Discovery |
| 11.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Biotechnology and Pharmaceutical Companies |
| 11.4.2.Academic Research Institutes |
| 11.4.3.Contract Research Organizations |
| 11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 11.5.7. |
| 12. Asia Pacific (APAC) Multiplex Biomarker Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Instrument |
| 12.1.2.Reagents and Kits |
| 12.1.3.Software |
| 12.2. Imaging Technique Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Tissue Microarray (TMA) |
| 12.2.2.Toponome Imaging System (TIS) |
| 12.2.3.Fluorescent In The Situ Hybridization (FISH) |
| 12.2.4.Immunofluorescence Assay (IF) |
| 12.2.5.Immunohistochemistry Assay (IHC) |
| 12.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Oncology |
| 12.3.2.Immunology |
| 12.3.3.Drug Safety |
| 12.3.4.Drug Discovery |
| 12.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Biotechnology and Pharmaceutical Companies |
| 12.4.2.Academic Research Institutes |
| 12.4.3.Contract Research Organizations |
| 12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Multiplex Biomarker Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Instrument |
| 13.1.2.Reagents and Kits |
| 13.1.3.Software |
| 13.2. Imaging Technique Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Tissue Microarray (TMA) |
| 13.2.2.Toponome Imaging System (TIS) |
| 13.2.3.Fluorescent In The Situ Hybridization (FISH) |
| 13.2.4.Immunofluorescence Assay (IF) |
| 13.2.5.Immunohistochemistry Assay (IHC) |
| 13.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Oncology |
| 13.3.2.Immunology |
| 13.3.3.Drug Safety |
| 13.3.4.Drug Discovery |
| 13.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Biotechnology and Pharmaceutical Companies |
| 13.4.2.Academic Research Institutes |
| 13.4.3.Contract Research Organizations |
| 13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Multiplex Biomarker Imaging Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Instrument |
| 14.1.2.Reagents and Kits |
| 14.1.3.Software |
| 14.2. Imaging Technique Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Tissue Microarray (TMA) |
| 14.2.2.Toponome Imaging System (TIS) |
| 14.2.3.Fluorescent In The Situ Hybridization (FISH) |
| 14.2.4.Immunofluorescence Assay (IF) |
| 14.2.5.Immunohistochemistry Assay (IHC) |
| 14.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Oncology |
| 14.3.2.Immunology |
| 14.3.3.Drug Safety |
| 14.3.4.Drug Discovery |
| 14.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Biotechnology and Pharmaceutical Companies |
| 14.4.2.Academic Research Institutes |
| 14.4.3.Contract Research Organizations |
| 14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Bio-rad Laboratories Inc. (U.S.) |
| 15.2.2.Abcam plc. (U.K.) |
| 15.2.3.Perkin Elmer, Inc. (U.S.) |
| 15.2.4.Thermo Fisher Scientific, Inc. (U.S.) |
| 15.2.5.Merck KGaA (Germany) |
| 15.2.6.Aushon BioSystems Ltd. (U.S.) |
| 15.2.7.ToposNomos Ltd (Germany) |
| 15.2.8.Ventana Medical Systems, Inc. (U.S.) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
